Antonio Risitano
Federico II Medical School, Haematology Division, Napels
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Antonio Risitano as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 06:38 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT02099747 · hATG+CsA vs hATG+CsA+Eltrombopag for SAAEuropean Society for Blood and Marrow Transplantation · completed · Severe Aplastic Anemia · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 06:38 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 06:38 UTC. The ranking covers the 200 most relevant of 37 PubMed records, and a shared surname and initials can bring in a namesake. All 37 on PubMed
- The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria.N Engl J Med · 20061,004 citationsRCR 23.6
- 505 citationsRCR 12.8
- Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host Disease.N Engl J Med · 2016495 citationsRCR 18.6
- 442 citationsRCR 11.2
- Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria.N Engl J Med · 2021351 citationsRCR 21.9
- Ravulizumab (ALXN1210) vs eculizumab in C5-inhibitor-experienced adult patients with PNH: the 302 study.Blood · 2019317 citationsRCR 14.8
- Long-term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria.Br J Haematol · 2013309 citationsRCR 10.3
- Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia.N Engl J Med · 2022257 citationsRCR 20.2
- Eculizumab in Pregnant Patients with Paroxysmal Nocturnal Hemoglobinuria.N Engl J Med · 2015231 citationsRCR 9.6
- 156 citationsRCR 5.1